Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing

2024-11-21T09:17:10+02:00November 21, 2024|Investor Information, Press Releases, Psychedelic News|

Psyence Biomed today announced the favorable outcome of the Nasdaq Listing Qualifications Hearing that was held on October 31st, 2024. The Nasdaq Hearings Panel has granted Psyence Biomed an extension until December 31st, 2024, to demonstrate compliance with all Nasdaq continued listing rules.